Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 3 (2006), Issue 10 (October)

1. Hyperglycemia after repeated periocular dexamethasone injections in patients with diabetes.
   Ophthalmology, 113(10): 1720-3. [Abstract] [Full-text]
2. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema.
   Ophthalmology, 113(10): 1706-12. [Abstract] [Full-text]
3. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
   Ophthalmology, 113(10): 1695.e1-15. [Abstract] [Full-text]
4. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany.
   J Am Coll Cardiol, 48(7): 1369-77. [Abstract] [Full-text]
5. VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits.
   FASEB J, 20(12): 2159-61. [Abstract] [Full-text]
6. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
   Ophthalmology, 113(10): 1713-9. [Abstract] [Full-text]
7. Is diabetes mellitus a risk factor for open-angle glaucoma? The Rotterdam Study.
   Ophthalmology, 113(10): 1827-31. [Abstract] [Full-text]
8. Predictors of urinary incontinence in a prospective cohort of postmenopausal women.
   Obstet Gynecol, 108(4): 855-62. [Abstract] [Full-text]
9. Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy.
   Am J Ophthalmol, 142(4): 685-8. [Abstract] [Full-text]
10. The influence of diabetes and lower limb arterial disease on cutaneous foot perfusion.
    J Vasc Surg, 44(4): 770-5. [Abstract] [Full-text]
11. Antioxidative enzyme and glutathione S-transferase activities in diabetic rats exposed to long-term ASA treatment.
    Life Sci, 79(19): 1804-11. [Abstract] [Full-text]
12. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study.
    Pediatrics, 118(4): 1510-8. [Abstract] [Full-text]
13. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Pediatrics, 118(4): e1244-9. [Abstract] [Full-text]
14. Early impairment of beta-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes.
    Nutr Metab Cardiovasc Dis, 16(7): 485-93. [Abstract] [Full-text]
15. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy.
    Nutr Metab Cardiovasc Dis, 16(7): 477-84. [Abstract] [Full-text]
16. Postprandial modulation of serum paraoxonase activity and concentration in diabetic and non-diabetic subjects.
    Nutr Metab Cardiovasc Dis, 16(7): 457-65. [Abstract] [Full-text]
17. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.
    Circulation, 114(14): 1522-30. [Abstract] [Full-text]
18. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.
    Nutr Metab Cardiovasc Dis, 16(7): 453-6. [Abstract] [Full-text]
19. Management of Type 2 diabetes: the role of incretin mimetics.
    Expert Opin Pharmacother, 7(15): 2095-105. [Abstract] [Full-text]
20. Recent evidence of sustained benefit with exenatide in Type 2 diabetes.
    Expert Opin Pharmacother, 7(14): 2003-6. [Abstract] [Full-text]
21. Evaluating hospital costs in type 2 diabetes care: does the choice of the model matter?
    Curr Med Res Opin, 22(10): 1965-71. [Abstract] [Full-text]
22. Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
    Curr Med Res Opin, 22(10): 1939-47. [Abstract] [Full-text]
23. Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus.
    Curr Med Res Opin, 22(10): 1921-6. [Abstract] [Full-text]
24. Expression and functional characteristics of tubular transporters: P-glycoprotein, PEPT1, and PEPT2 in renal mass reduction and diabetes.
    Am J Physiol Renal Physiol, 291(5): F972-80. [Abstract] [Full-text]
25. Glucose-evoked alterations in connexin43-mediated cell-to-cell communication in human collecting duct: a possible role in diabetic nephropathy.
    Am J Physiol Renal Physiol, 291(5): F1045-51. [Abstract] [Full-text]
26. Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye.
    Arch Ophthalmol, 124(10): 1457-62. [Abstract] [Full-text]
27. Mannose-binding lectin and mortality in type 2 diabetes.
    Arch Intern Med, 166(18): 2007-13. [Abstract] [Full-text]
28. Effect of ramipril on the incidence of diabetes.
    N Engl J Med, 355(15): 1551-62. [Abstract] [Full-text]
29. Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).
    BMC Cardiovasc Disord, 6: 39. [Abstract] [Full-text]
30. Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement.
    Kidney Int, 70(9): 1629-35. [Abstract] [Full-text]
31. Neurologic complications after neuraxial anesthesia or analgesia in patients with preexisting peripheral sensorimotor neuropathy or diabetic polyneuropathy.
    Anesth Analg, 103(5): 1294-9. [Abstract] [Full-text]
32. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats.
    Eur J Pharmacol, 550(1): 173-9. [Abstract] [Full-text]
33. Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population.
    CMAJ, 175(9): 1071-7. [Abstract] [Full-text]
34. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
    Neurology, 67(8): 1411-20. [Abstract] [Full-text]
35. Microvascular complications of diabetes.
    Nurs Clin North Am, 41(4): 719-36, ix. [Abstract] [Full-text]
36. Diabetic neuropathies: diagnosis and treatment.
    Nurs Clin North Am, 41(4): 697-717, ix. [Abstract] [Full-text]
37. Diabetes mellitus and cardiovascular disease.
    Nurs Clin North Am, 41(4): 681-95, viii-ix. [Abstract] [Full-text]
38. Psychosocial and psychiatric challenges of diabetes mellitus.
    Nurs Clin North Am, 41(4): 667-80, viii. [Abstract] [Full-text]
39. Diabetes self-management education.
    Nurs Clin North Am, 41(4): 655-66, viii. [Abstract] [Full-text]
40. Behavioral interventions for diabetes self-management.
    Nurs Clin North Am, 41(4): 641-54, viii. [Abstract] [Full-text]
41. Interventions for the family with diabetes.
    Nurs Clin North Am, 41(4): 625-39, vii. [Abstract] [Full-text]
42. Vulnerable populations with diabetes mellitus.
    Nurs Clin North Am, 41(4): 605-23, vii. [Abstract] [Full-text]
43. Pharmacologic interventions for type 1 and type 2 diabetes.
    Nurs Clin North Am, 41(4): 589-604, vii. [Abstract] [Full-text]
44. Lifestyle intervention for prevention and treatment of type 2 diabetes.
    Nurs Clin North Am, 41(4): 567-88, vii. [Abstract] [Full-text]
45. Women and diabetes.
    Nurs Clin North Am, 41(4): 549-65, vi. [Abstract] [Full-text]
46. Type 2 diabetes mellitus.
    Nurs Clin North Am, 41(4): 531-47, vi. [Abstract] [Full-text]
47. Type 1 diabetes.
    Nurs Clin North Am, 41(4): 513-30, vi. [Abstract] [Full-text]
48. Economics of diabetes mellitus.
    Nurs Clin North Am, 41(4): 499-511, v-vi. [Abstract] [Full-text]
49. Epidemiologic perspectives of risk for developing diabetes and diabetes complications.
    Nurs Clin North Am, 41(4): 487-98, v. [Abstract] [Full-text]
50. Brain phospholipid and triglyceride fatty acid content and pattern in Type 1 and Type 2 diabetic rats.
    Neurosci Lett, 409(1): 75-9. [Abstract] [Full-text]
51. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis.
    Diabetes Care, 29(11): 2518-27. [Abstract] [Full-text]
52. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.
    Diabetes Care, 29(11): 2498-503. [Abstract] [Full-text]
53. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals.
    Diabetes Care, 29(11): 2489-97. [Abstract] [Full-text]
54. Celiac disease and risk of subsequent type 1 diabetes: a general population cohort study of children and adolescents.
    Diabetes Care, 29(11): 2483-8. [Abstract] [Full-text]
55. Cigarette smoking is associated with low glomerular filtration rate in male patients with type 2 diabetes.
    Diabetes Care, 29(11): 2467-70. [Abstract] [Full-text]
56. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection.
    Diabetes Care, 29(11): 2462-6. [Abstract] [Full-text]
57. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.
    Diabetes Care, 29(11): 2457-61. [Abstract] [Full-text]
58. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years' follow-up.
    Diabetes Care, 29(11): 2452-6. [Abstract] [Full-text]
59. Combination of multiple genetic risk factors is synergistically associated with carotid atherosclerosis in Japanese subjects with type 2 diabetes.
    Diabetes Care, 29(11): 2445-51. [Abstract] [Full-text]
60. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetes.
    Diabetes Care, 29(11): 2439-44. [Abstract] [Full-text]
61. Evaluation of a new measure of blood glucose variability in diabetes.
    Diabetes Care, 29(11): 2433-8. [Abstract] [Full-text]
62. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study.
    Diabetes Care, 29(11): 2427-32. [Abstract] [Full-text]
63. The burden and treatment of diabetes in elderly individuals in the u.s.
    Diabetes Care, 29(11): 2415-9. [Abstract] [Full-text]
64. Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients.
    Diabetes Care, 29(11): 2409-14. [Abstract] [Full-text]
65. Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study.
    Diabetes Care, 29(11): 2403-8. [Abstract] [Full-text]
66. Incidence of type 1 diabetes in Philadelphia is higher in black than white children from 1995 to 1999: epidemic or misclassification?
    Diabetes Care, 29(11): 2391-5. [Abstract] [Full-text]
67. Does coffee consumption reduce the risk of type 2 diabetes in individuals with impaired glucose?
    Diabetes Care, 29(11): 2385-90. [Abstract] [Full-text]
68. Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).
    Diabetes Care, 29(11): 2378-84. [Abstract] [Full-text]
69. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Diabetes Care, 29(11): 2371-7. [Abstract] [Full-text]
70. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
    Diabetes Care, 29(11): 2365-70. [Abstract] [Full-text]
71. Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes.
    Diabetes Care, 29(11): 2361-4. [Abstract] [Full-text]
72. Durability of insulin pump use in pediatric patients with type 1 diabetes.
    Diabetes Care, 29(11): 2355-60. [Abstract] [Full-text]
73. Parity and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study.
    Diabetes Care, 29(11): 2349-54. [Abstract] [Full-text]
74. Quality of diabetes care in the middle- and high-income group populace: the Delhi Diabetes Community (DEDICOM) survey.
    Diabetes Care, 29(11): 2341-8. [Abstract] [Full-text]
75. Coccidioidomycosis in patients with diabetes mellitus.
    Am J Med, 119(11): 964-9. [Abstract] [Full-text]
76. Non-invasive glucose monitoring in patients with diabetes: a novel system based on impedance spectroscopy.
    Biosens Bioelectron, 22(5): 598-604. [Abstract] [Full-text]
77. Racial/Ethnic and social class differences in preventive care practices among persons with diabetes.
    BMC Public Health, 6: 259. [Abstract] [Full-text]
78. Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes.
    Biochem Biophys Res Commun, 351(1): 165-70. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.